NIV-143 100 mg Pill - beige peach capsule/oblong, 18mm
Pill with imprint NIV-143 100 mg is Beige / Peach, Capsule/Oblong and has been identified as Temozolomide 100 mg. It is supplied by Nivagen Pharmaceuticals, Inc.
Temozolomide is used in the treatment of Glioblastoma Multiforme; Anaplastic Astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NIV-143 100 mg
Temozolomide
- Imprint
- NIV-143 100 mg
- Strength
- 100 mg
- Color
- Beige / Peach
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Nivagen Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 75834-0143
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
sodium starch glycolate type A potato,
tartaric acid,
stearic acid,
gelatin,
titanium dioxide,
ferric oxide yellow,
ferric oxide red,
shellac,
butyl alcohol,
isopropyl alcohol,
propylene glycol,
ammonia,
potassium hydroxide,
ferrosoferric oxide,
water,
alcohol
Note: Inactive ingredients may vary.
More about temozolomide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- En español
Patient resources
- Temozolomide oral/injection drug information
- Temozolomide (Intravenous) (Advanced Reading)
- Temozolomide (Oral) (Advanced Reading)
- Temozolomide Capsules
- Temozolomide Injection
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
